Browse medicines, page 9 of 9
Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.
Medicine type
Approval status
AllApproved in the United States (FDA)Approved in the European Union (EMA)In Phase 3 testingIn Phase 2 testingUsed in a way not covered by an approval, or made by a compounding pharmacyDietary supplement; not FDA-approved as a medicineFDA accelerated approval (based on an earlier result expected to predict benefit; follow-up evidence may be required)Laboratory or animal-stage researchControlled substance; no approved US useWithdrawn from the market
Amount of information
Showing 481–526 of 526 records
Ranibizumab-Nuna (Byooviz)
Protein medicineApproved in the United States (FDA)Expanded recordRetifanlimab-Dlwr (Zynyz)
Protein medicineApproved in the United States (FDA)Expanded recordRituximab-Abbs (Truxima)
Protein medicineApproved in the United States (FDA)Expanded recordRituximab-Pvvr (Ruxience)
Protein medicineApproved in the United States (FDA)Expanded recordSebelipase alfa (Kanuma)
Protein medicineApproved in the United States (FDA)Expanded recordStreptococcus Pneumoniae Type 11a Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 19f Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 4 Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 8 Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordTafasitamab-Cxix (Monjuvi)
Protein medicineApproved in the United States (FDA)Expanded recordTalquetamab-Tgvs (Talvey)
Protein medicineApproved in the United States (FDA)Expanded recordTechnetium Tc99m Albumin Aggregated (Pulmotech Maa)
Protein medicineApproved in the United States (FDA)Expanded recordTeprotumumab-Trbw (Tepezza)
Protein medicineApproved in the United States (FDA)Expanded recordTezepelumab-Ekko (Tezspire)
Protein medicineApproved in the United States (FDA)Expanded recordTislelizumab-Jsgr (Tevimbra)
Protein medicineApproved in the United States (FDA)Expanded recordTocilizumab-Aazg (Tyenne)
Protein medicineApproved in the United States (FDA)Expanded recordTocilizumab-Anoh (Avtozma)
Protein medicineApproved in the United States (FDA)Expanded recordTrastuzumab-Anns (Kanjinti)
Protein medicineApproved in the United States (FDA)Expanded recordTrastuzumab-Dkst (Ogivri)
Protein medicineApproved in the United States (FDA)Expanded recordTrastuzumab-Dttb (Ontruzant)
Protein medicineApproved in the United States (FDA)Expanded recordTrastuzumab-Strf (Hercessi)
Protein medicineApproved in the United States (FDA)Expanded recordUblituximab-Xiiy (Briumvi)
Protein medicineApproved in the United States (FDA)Expanded recordUrofollitropin (Bravelle / Fertinex / Metrodin)
Protein medicineApproved in the United States (FDA)Expanded recordUstekinumab-Aekn (Selarsdi)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who are candidates for phototherapy or syste
Ustekinumab-Auub (Wezlana)
Protein medicineApproved in the United States (FDA)Expanded recordUstekinumab-Hmny (Starjemza)
Protein medicineApproved in the United States (FDA)Expanded recordUstekinumab-Stba (Steqeyma)
Protein medicineApproved in the United States (FDA)Expanded recordUstekinumab-Ttwe (Pyzchiva)
Protein medicineApproved in the United States (FDA)Expanded recordVeligrotug-Vvze (Lumvoa)
Protein medicineApproved in the United States (FDA)Expanded recordVestronidase alfa (Mepsevii)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Mucopolysaccharidosis VII
Vestronidase Alfa-Vjbk (Mepsevii)
Protein medicineApproved in the United States (FDA)Expanded recordZanidatamab-Hrii (Ziihera)
Protein medicineApproved in the United States (FDA)Expanded recordZenocutuzumab-Zbco (Bizengri)
Protein medicineApproved in the United States (FDA)Expanded recordRanibizumab-Leyk (Nufymco)
Protein medicineApproved in the United States (FDA)Expanded recordRisankizumab-Rzaa (Skyrizi)
Protein medicineApproved in the United States (FDA)Expanded recordStreptococcus Pneumoniae Type 3 Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Capvaxive / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 5 Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordTagraxofusp-Erzs (Elzonris)
Protein medicineApproved in the United States (FDA)Expanded recordTividenofusp Alfa-Eknm (Avlayah)
Protein medicineApproved in the United States (FDA)Expanded recordTrastuzumab-Qyyp (Trazimera)
Protein medicineApproved in the United States (FDA)Expanded recordTremelimumab-Actl (Imjudo)
Protein medicineApproved in the United States (FDA)Expanded recordVeligrotug (Lumvoa)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Thyroid eye disease regardless of thyroid eye disease activity or duration
Rituximab-Arrx (Riabni)
Protein medicineApproved in the United States (FDA)Expanded recordSotatercept-Csrk (Winrevair)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Pulmonary arterial hypertension (PAH, Group 1 pulmonary hypertension) to improve exercise capacity and World Health Organization
Thyrotropin alfa (Thyrogen)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
THYROGEN ® is a thyroid stimulating hormone indicated for: Adjunctive Diagnostic Tool for Well-Differentiated Thyroid Cancer: Use as an adjunctive diagnostic tool for serum thyroglobulin (Tg) testing with or without radioiodine imaging in the follow-up of patients with well-differentiated thyroid cancer who have previously undergone thyroidectomy. ( 1.1 ) Limitations of Use : THYROGEN-stimulated Tg levels are generally lower than, and do not correlate with Tg levels after thyroid hormone withdrawal.
Toripalimab-Tpzi (Loqtorzi)
Protein medicineApproved in the United States (FDA)Expanded record